This brand name is authorized in Germany, Finland, France
The drug NOVOPULMON contains one active pharmaceutical ingredient (API):
|
1
Budesonide
UNII Q3OKS62Q6X - BUDESONIDE
|
|
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03BA02 | Budesonide | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00428519, 00771884, 00771909, 00771915, 01424564, 01424593, 01424601, 01512423, 04972935, 04972941, 04990583, 06966117, 06966229 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 072752, 072761, 121672 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60468092, 67008036 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
